Literature DB >> 14996549

Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain.

S Mato1, A Pazos.   

Abstract

It has been suggested that cannabimimetic drugs could be of interest in the treatment of several nervous disorders. Thus, it is important to analyse the distribution and properties of cannabinoid (CB) receptors directly in human brain. As postmortem human tissue is subjected to the effects of several biological variables, we have analyzed by autoradiography the influence of age, postmortem delay and freezing storage period (at -25 degrees C) on two parameters corresponding to cannabinoid CB1 receptors in human frontal cortex: receptor density and degree of activation of G-proteins ([35S]GTPgammaS assays). A significant decrease in the amount of both receptor density and agonist-stimulated G-protein activity was observed with age, revealing a mean reduction of about 10% per decade. In contrast, no significant correlations were found with postmortem delay either for CB1 receptors density or functionality. Finally, both parameters (receptor density and [35S]GTPgammaS response) were significantly reduced with freezing storage period at -25 degrees C in frontal cortical layers. Non-linear analysis of these data yielded values between 12 and 24 months of storage for a 50% reduction. In conclusion, when studying CB1 receptor properties in human brain samples, a careful analysis (and matching) for variables such as age and freezing storage period has to be carried out.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996549     DOI: 10.1016/j.neuropharm.2003.11.004

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  17 in total

1.  Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

Authors:  Belén G Ramírez; Cristina Blázquez; Teresa Gómez del Pulgar; Manuel Guzmán; María L de Ceballos
Journal:  J Neurosci       Date:  2005-02-23       Impact factor: 6.167

2.  Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders.

Authors:  Susana Mato; Fuencisla Pilar-Cuéllar; Elsa M Valdizán; Javier González-Maeso; Rafael Rodríguez-Puertas; Javier Meana; Joan Sallés; Benedicto Crespo-Facorro; Ángel Pazos
Journal:  Biochem Pharmacol       Date:  2018-08-10       Impact factor: 5.858

3.  Age-related changes in regulator of G-protein signaling (RGS)-10 expression in peripheral and central immune cells may influence the risk for age-related degeneration.

Authors:  George T Kannarkat; Jae-Kyung Lee; Chenere P Ramsey; Jaegwon Chung; Jianjun Chang; Isadora Porter; Danielle Oliver; Kennie Shepherd; Malú G Tansey
Journal:  Neurobiol Aging       Date:  2015-02-13       Impact factor: 4.673

Review 4.  Aging circadian rhythms and cannabinoids.

Authors:  Erik L Hodges; Nicole M Ashpole
Journal:  Neurobiol Aging       Date:  2019-03-25       Impact factor: 4.673

5.  Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression.

Authors:  Beata Karolewicz; Craig A Stockmeier; Gregory A Ordway
Journal:  Neuropsychopharmacology       Date:  2005-08       Impact factor: 7.853

6.  Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.

Authors:  Monika Feliszek; Laura Bindila; Beat Lutz; Andreas Zimmer; Andras Bilkei-Gorzo; Eberhard Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-17       Impact factor: 3.000

7.  Prenatal corticosterone and adolescent URB597 administration modulate emotionality and CB1 receptor expression in mice.

Authors:  Chiara Ceci; Virginia Mela; Simone Macrì; Eva M Marco; Maria-Paz Viveros; Giovanni Laviola
Journal:  Psychopharmacology (Berl)       Date:  2013-12-06       Impact factor: 4.530

8.  Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain.

Authors:  M Palkovits; J Harvey-White; J Liu; Z S Kovacs; M Bobest; G Lovas; A G Bagó; G Kunos
Journal:  Neuroscience       Date:  2008-02-05       Impact factor: 3.590

9.  Heterotrimeric g proteins: insights into the neurobiology of mood disorders.

Authors:  Javier González-Maeso; J Javier Meana
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

10.  [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.

Authors:  H Donald Burns; Koen Van Laere; Sandra Sanabria-Bohórquez; Terence G Hamill; Guy Bormans; Wai-si Eng; Ray Gibson; Christine Ryan; Brett Connolly; Shil Patel; Stephen Krause; Amy Vanko; Anne Van Hecken; Patrick Dupont; Inge De Lepeleire; Paul Rothenberg; S Aubrey Stoch; Josee Cote; William K Hagmann; James P Jewell; Linus S Lin; Ping Liu; Mark T Goulet; Keith Gottesdiener; John A Wagner; Jan de Hoon; Luc Mortelmans; Tung M Fong; Richard J Hargreaves
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.